Diagnóstico molecular de neumonías bacterianas atípicas provenientes de la comunidad. Paraguay (2014-2017)
DOI:
https://doi.org/10.32480/rscp.2018-23-1.139-146Palabras clave:
Neumonías atípicas, Legionella pneumophila, Mycoplasma pneumoniae, Chlamydophila pneumoniae, PCRResumen
Objetivos: Determinar la frecuencia de neumonías bacterianas atípicas causadas por Legionella pneumophila, Mycoplasma pneumoniae y Chlamydophila pneumoniae, en niños y adultos de Paraguay durante el periodo 2014-2017 por técnicas moleculares.
Materiales y métodos: se incluyeron en este estudio 148 muestras de líquido pleural de niños y adultos con diagnóstico de neumonía adquirida en la comunidad (NAC) durante el periodo 2014 a febrero de 2017. Las muestras fueron remitidas al Laboratorio Central de Salud Pública por los Centros Centinelas y Centros Colaboradores de la Red de Vigilancia de Meningitis y Neumonías.
Resultados: La frecuencia general de neumonías atípicas resultó 1.4 % (2/148). Se detectó Legionella pneumophila en 0.7% (1/148) de los pacientes con sospecha de neumonía y un caso Mycoplasma pneumoniae en 0.7% (1/148).
Conclusión: Los agentes atípicos presentan manifestaciones inespecíficas y variables de un caso a otro, haciéndolas difíciles de distinguir de otras etiologías. Los nuevos enfoques del diagnóstico microbiológico son prometedores, se espera que las pruebas de diagnóstico molecular para estos patógenos sean importantes herramientas en el laboratorio clínico.
Métricas
Cargando métricas ...
Descargas
Los datos de descarga aún no están disponibles.
Referencias
1. Murdoch DR, Chambers ST. Atypical pneumonia: time to breathe new life into a useful term? Lancet Infect Dis 2009;9(8):512-519.
2. Berebichez-Fridman R, Blachman-Braun R, Azrad-Daniel S, Vázquez-Campuzano R, Vázquez-López R. Atypical pneumonias caused by Legionella pneumophila, Chlamydophila pneumoniae and Mycoplasma pneumonia. Rev Med Hosp Gen Méx. 2015;78(4):188-195.
3. Parra W. Neumonías atípicas. Neumol Pediatr. 2013;(8):74-78.
4. Sepúlveda A, Castet A, Bertrand P. Atypical pneumonia: mycoplasma and chlamydia pneumoniae. Making an accurate diagnosis and deciding when to treat. Neumol Pediatr. 2015;10(3):118-123.
5. Principi N, Esposito S, Blasi F Allegra L. Role of Mycoplasma pneumoniae and Chlamydia pneumoniae in Children with Community-Acquired Lower Respiratory Tract Infections. Clinical Infectious Diseases. 2001;32(9):1281–1289. doi: https://doi.org/10.1086/319981
6. Cunha B. The atypical pneumonias: clinical diagnosis and importance. Clinical Microbiology and Infection. 2006;12:12–24. doi:10.1111/j.1469-0691.2006.01393.x
7. Remington LT, Sligl W. Community-acquired pneumonia. Curr Opin Pulm Med. 2014;20(3) 215–24.
8. Inostroza E, Pinto R. Pneumonia due to atypical agents in children. Revista Médica Clinica Las Condes. 2017;(28):90-96.
9. Marchello C, Dale AP, Thai TN, Han DS, Ebell MH. Prevalence of Atypical Pathogens in Patients With Cough and Community-Acquired Pneumonia: A Meta- Analysis. Annals of Family Medicine. 2016;14(6):552-566. doi:10.1370/afm.1993
10. Phin N, Parry-Ford F, Harrison T, et al. Epidemiology and clinical management of Legionnaires’ disease. Lancet Infect Dis. 2014;14(10):1011–1021.
11. Omori R, Nakata Y, Tessmer HL, Suzuki S, Shibayama K. The determinant of periodicity in Mycoplasma pneumoniae incidence: an insight from mathematical modelling. Sci Rep. 2015;5:14473.
12. Klement EDF. Talkington O, Wasserzug R, Kayouf N, Davidovitch R, Dumke Y, Bar-Zeev R, Merav J, Boxman WL, Thacker D, Wolf T, Lazarovich Y, Shemer-Avni D, Glikman E, Jacobs I, Grotto C, Block, Nir-Paz R. Identification of risk factors for infection in an outbreak of Mycoplasma pneumoniae respiratory tract disease. Clin. Infect. Dis. 2006;43:1239-1245.
13. Waites KB, Talkington DF. Mycoplasma pneumoniae and its role as a human pathogen. Clin. Microbiol. Rev. 2004;17:697-728.
14. Zhan P, Suo LJ, Qian Q, et al. Chlamydia pneumoniae infection and lung cancer risk: a meta-analysis. Eur J Cancer. 2011;47(5):742–747.
15. Ngeow YF, Suwanjutha S, Chantarojanasriri T, Wang F, Saniel M, Alejandria M, Hsueh PR, Ping-Ing PR, Park SC, Sohn J, Aziah AM, Liu Y, Seto WH, Ngan CC, Hadiarto M, Hood A, Cheong YM. An Asian study on the prevalence of atypical respiratory pathogens in community-acquired pneumonia. Int. J. Infect. Dis. 2005;9:144-153.
16. Thurman KA, Warner AK, Cowart KC, Benitez AJ, Winchell JM. Detection of Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella spp. in clinical specimens using a single-tube multiplex real-time PCR assay. Diagn Microbiol Infect Dis 2011;70:1–9.
17. Allegra L, Blasi F. Problems and perspectives in the treatment of respiratory infections caused by atypical pathogens. Pulm Pharmacol Ther. 2001;14:21–27.
18. Thibodeau KP, Viera AJ. Atypical pathogens and challenges in community-acquired pneumonia. Am Fam Physician. 2004;69(7):1699-706.
19. Bartlett JG. Is activity against "atypical" pathogens necessary in the treatment protocols for community-acquired pneumonia? Issues with combination therapy. Clin Infect Dis. 2008;47(3):232-6. doi: 10.1086/591409.
20. Templeton KE, Scheltinga SA, van den Eeden WC, Graffelman AW, van den Broek PJ, Claas EC. Improved diagnosis of the etiology of community-acquired pneumonia with real-time polymerase chain reaction. Clin Infect Dis 2005;41:345–351.
21. Räty R, Rönkkö E, Kleemola M. Sample type is crucial to the diagnosis of Mycoplasma pneumoniae pneumonia by PCR. J Med Microbiol. 2005;54:287–291.
22. Chang H, Chan L, Shao P, Lee P, Chen J, Lee C. Lu C. Huang Li. Comparison of real-time polymerase chain reaction and serological test for the confirmation of Mycoplasma penumoniae infection in children with clinical diagnosis of atypical pneumonia. J Microbiol, Immunol Infect. 2014;47:137-144.
23. Strålin K, Korsgaard J, Olcén P. Evaluation of a multiplex PCR for bacterial pathogens applied to bronchoalveolar lavage. European Respiratory Journal. 2006;28:568-575. DOI: 10.1183/09031936.06.00006106
24. Plnar A, Bozdemir N, Kocagöz T, Alaçam R. Rapid detection of bacterial atypical pneumonia agents by multiplex PCR. Cent Eur J Publ Health2004;12(1):3-5.
25. Miranda J. Atypical microorganisms in children with community - Acquired pneumonia: EsSalud Grau Emergency Hospital - Period 2008. Acta méd. Peruana. 2012;29(1):17-22.
26. Garcia-Vidal C, Labori M, Viasus D, Simonetti A, Garcia-Somoza D, Dorca J, et al. Rainfall Is a Risk Factor for Sporadic Cases of Legionella pneumophila Pneumonia. PLoS ONE. 2013;8(4):e61036. Disponible en: https://doi.org/10.1371/journal.pone.0061036
27. Chen ZR, Yan YD, Wang YQ, ZhuH., ShaoX.., Xu J. Epidemiology of community-acquired Mycoplasma pneumoniae respiratory tract infections among hospitalized Chinese children, including relationships with meteorological factors. Hippokratia. 2013;17: 20–26.
28. Cosentini R, Tarsia P, Blasi F, Roma E, Allegra L. Community-acquired pneumonia: role of atypical organisms. Monaldi Arch Chest Dis. 2001;56(6):527-34.
29. Samransamruajkit R, Jitchaiwat S, Wachirapaes W, Deerojanawong J, Sritippayawan S, Prapphal N: Prevalence of Mycoplasma and Chlamydia pneumonia in severe community-acquired pneumonia among hospitalized children in Thailand. Jpn J Infect Dis. 2008;61:36-39.
30. Gadsby NJ, Helgason KO, Dickson EM, Mills JM, Lindsay DS, Edwards GF, Hanson MF, Templeton KE, ESCMID Study Group for Molecular Diagnostics, ESCMID Study Group for Legionella Infections, Basel, Molecular diagnosis of Legionella infections—clinical utility of front-line screening as part of a pneumonia diagnostic algorithm. J Infect. 2016;72:161–170.
31. Torres A, Lee N, Cilloniz C, Vila J, Van der Eerden M. 2016. Laboratory diagnosis of pneumonia in the molecular age. Eur Respir. 2016;48:1764–1778. doi: 10.1183/13993003.01144-2016.
2. Berebichez-Fridman R, Blachman-Braun R, Azrad-Daniel S, Vázquez-Campuzano R, Vázquez-López R. Atypical pneumonias caused by Legionella pneumophila, Chlamydophila pneumoniae and Mycoplasma pneumonia. Rev Med Hosp Gen Méx. 2015;78(4):188-195.
3. Parra W. Neumonías atípicas. Neumol Pediatr. 2013;(8):74-78.
4. Sepúlveda A, Castet A, Bertrand P. Atypical pneumonia: mycoplasma and chlamydia pneumoniae. Making an accurate diagnosis and deciding when to treat. Neumol Pediatr. 2015;10(3):118-123.
5. Principi N, Esposito S, Blasi F Allegra L. Role of Mycoplasma pneumoniae and Chlamydia pneumoniae in Children with Community-Acquired Lower Respiratory Tract Infections. Clinical Infectious Diseases. 2001;32(9):1281–1289. doi: https://doi.org/10.1086/319981
6. Cunha B. The atypical pneumonias: clinical diagnosis and importance. Clinical Microbiology and Infection. 2006;12:12–24. doi:10.1111/j.1469-0691.2006.01393.x
7. Remington LT, Sligl W. Community-acquired pneumonia. Curr Opin Pulm Med. 2014;20(3) 215–24.
8. Inostroza E, Pinto R. Pneumonia due to atypical agents in children. Revista Médica Clinica Las Condes. 2017;(28):90-96.
9. Marchello C, Dale AP, Thai TN, Han DS, Ebell MH. Prevalence of Atypical Pathogens in Patients With Cough and Community-Acquired Pneumonia: A Meta- Analysis. Annals of Family Medicine. 2016;14(6):552-566. doi:10.1370/afm.1993
10. Phin N, Parry-Ford F, Harrison T, et al. Epidemiology and clinical management of Legionnaires’ disease. Lancet Infect Dis. 2014;14(10):1011–1021.
11. Omori R, Nakata Y, Tessmer HL, Suzuki S, Shibayama K. The determinant of periodicity in Mycoplasma pneumoniae incidence: an insight from mathematical modelling. Sci Rep. 2015;5:14473.
12. Klement EDF. Talkington O, Wasserzug R, Kayouf N, Davidovitch R, Dumke Y, Bar-Zeev R, Merav J, Boxman WL, Thacker D, Wolf T, Lazarovich Y, Shemer-Avni D, Glikman E, Jacobs I, Grotto C, Block, Nir-Paz R. Identification of risk factors for infection in an outbreak of Mycoplasma pneumoniae respiratory tract disease. Clin. Infect. Dis. 2006;43:1239-1245.
13. Waites KB, Talkington DF. Mycoplasma pneumoniae and its role as a human pathogen. Clin. Microbiol. Rev. 2004;17:697-728.
14. Zhan P, Suo LJ, Qian Q, et al. Chlamydia pneumoniae infection and lung cancer risk: a meta-analysis. Eur J Cancer. 2011;47(5):742–747.
15. Ngeow YF, Suwanjutha S, Chantarojanasriri T, Wang F, Saniel M, Alejandria M, Hsueh PR, Ping-Ing PR, Park SC, Sohn J, Aziah AM, Liu Y, Seto WH, Ngan CC, Hadiarto M, Hood A, Cheong YM. An Asian study on the prevalence of atypical respiratory pathogens in community-acquired pneumonia. Int. J. Infect. Dis. 2005;9:144-153.
16. Thurman KA, Warner AK, Cowart KC, Benitez AJ, Winchell JM. Detection of Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella spp. in clinical specimens using a single-tube multiplex real-time PCR assay. Diagn Microbiol Infect Dis 2011;70:1–9.
17. Allegra L, Blasi F. Problems and perspectives in the treatment of respiratory infections caused by atypical pathogens. Pulm Pharmacol Ther. 2001;14:21–27.
18. Thibodeau KP, Viera AJ. Atypical pathogens and challenges in community-acquired pneumonia. Am Fam Physician. 2004;69(7):1699-706.
19. Bartlett JG. Is activity against "atypical" pathogens necessary in the treatment protocols for community-acquired pneumonia? Issues with combination therapy. Clin Infect Dis. 2008;47(3):232-6. doi: 10.1086/591409.
20. Templeton KE, Scheltinga SA, van den Eeden WC, Graffelman AW, van den Broek PJ, Claas EC. Improved diagnosis of the etiology of community-acquired pneumonia with real-time polymerase chain reaction. Clin Infect Dis 2005;41:345–351.
21. Räty R, Rönkkö E, Kleemola M. Sample type is crucial to the diagnosis of Mycoplasma pneumoniae pneumonia by PCR. J Med Microbiol. 2005;54:287–291.
22. Chang H, Chan L, Shao P, Lee P, Chen J, Lee C. Lu C. Huang Li. Comparison of real-time polymerase chain reaction and serological test for the confirmation of Mycoplasma penumoniae infection in children with clinical diagnosis of atypical pneumonia. J Microbiol, Immunol Infect. 2014;47:137-144.
23. Strålin K, Korsgaard J, Olcén P. Evaluation of a multiplex PCR for bacterial pathogens applied to bronchoalveolar lavage. European Respiratory Journal. 2006;28:568-575. DOI: 10.1183/09031936.06.00006106
24. Plnar A, Bozdemir N, Kocagöz T, Alaçam R. Rapid detection of bacterial atypical pneumonia agents by multiplex PCR. Cent Eur J Publ Health2004;12(1):3-5.
25. Miranda J. Atypical microorganisms in children with community - Acquired pneumonia: EsSalud Grau Emergency Hospital - Period 2008. Acta méd. Peruana. 2012;29(1):17-22.
26. Garcia-Vidal C, Labori M, Viasus D, Simonetti A, Garcia-Somoza D, Dorca J, et al. Rainfall Is a Risk Factor for Sporadic Cases of Legionella pneumophila Pneumonia. PLoS ONE. 2013;8(4):e61036. Disponible en: https://doi.org/10.1371/journal.pone.0061036
27. Chen ZR, Yan YD, Wang YQ, ZhuH., ShaoX.., Xu J. Epidemiology of community-acquired Mycoplasma pneumoniae respiratory tract infections among hospitalized Chinese children, including relationships with meteorological factors. Hippokratia. 2013;17: 20–26.
28. Cosentini R, Tarsia P, Blasi F, Roma E, Allegra L. Community-acquired pneumonia: role of atypical organisms. Monaldi Arch Chest Dis. 2001;56(6):527-34.
29. Samransamruajkit R, Jitchaiwat S, Wachirapaes W, Deerojanawong J, Sritippayawan S, Prapphal N: Prevalence of Mycoplasma and Chlamydia pneumonia in severe community-acquired pneumonia among hospitalized children in Thailand. Jpn J Infect Dis. 2008;61:36-39.
30. Gadsby NJ, Helgason KO, Dickson EM, Mills JM, Lindsay DS, Edwards GF, Hanson MF, Templeton KE, ESCMID Study Group for Molecular Diagnostics, ESCMID Study Group for Legionella Infections, Basel, Molecular diagnosis of Legionella infections—clinical utility of front-line screening as part of a pneumonia diagnostic algorithm. J Infect. 2016;72:161–170.
31. Torres A, Lee N, Cilloniz C, Vila J, Van der Eerden M. 2016. Laboratory diagnosis of pneumonia in the molecular age. Eur Respir. 2016;48:1764–1778. doi: 10.1183/13993003.01144-2016.
Descargas
Publicado
13.10.2018
Número
Sección
Artículos Originales
Licencia
El/los autores autorizan a la Revista de la Sociedad Científica del Paraguay a publicar y difundir el articulo del cual son autores, por los medios que considere apropiado.
Cómo citar
1.
Diagnóstico molecular de neumonías bacterianas atípicas provenientes de la comunidad. Paraguay (2014-2017). Rev. Soc. cient. Py. [Internet]. 2018 Oct. 13 [cited 2025 Oct. 7];23(1):139-46. Available from: http://sociedadcientifica.org.py/ojs/index.php/rscpy/article/view/41
